Guidelines

Thrombosis in multiple myeloma: risk stratification, antithrombotic prophylaxis, and management of acute events. A consensus-based position paper from an ad hoc expert panel

Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University, Fondazione Policlinico A. Gemelli IRCCS, Rome
SSD Clinical Trial in Oncoematologia e Mieloma Multiplo, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino
Hematology and Transplant Unit, ASST Ospedale San Gerardo di Monza, Monza
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università degli Studi, Bologna
Section of Hematology, Department of General Surgery and Medical Specialties, University of Catania, and Division of Hematology, Policlinico “Rodolico”, Catania
Department of Medicine and Surgery, University of Milan Bicocca, Milan, Italy; Department of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo
Clinica di Ematologia Azienda Ospedaliero-Universitaria, Ospedali Riuniti di Ancona, Ancona
Hematology, Azienda Policlinico Umberto I, Sapienza University, Rome
Hematology Department, San Bortolo Hospital, Vicenza
SSD Thrombosis and Hemostasis Center, Azienda Ospedaliera “ SS Antonio e Biagio e C. Arrigo”, Alessandria
Center for the Study of Myelofibrosis, IRCCS Policlinico S. Matteo Foundation, Pavia
Haematologica Early view Jul 21, 2022 https://doi.org/10.3324/haematol.2022.280893